Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfol... Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease. Show more
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.835 | -4.28205128205 | 19.5 | 20.11 | 18.4 | 1077231 | 19.43499583 | CS |
4 | -7.245 | -27.9621767657 | 25.91 | 27.09 | 18.4 | 1592061 | 22.03047798 | CS |
12 | -0.075 | -0.400213447172 | 18.74 | 27.34 | 17.05 | 1459968 | 21.35149949 | CS |
26 | -7.005 | -27.2886638099 | 25.67 | 30.41 | 17.05 | 1219522 | 22.44268935 | CS |
52 | -11.835 | -38.8032786885 | 30.5 | 39.83 | 17.05 | 1274843 | 26.05187207 | CS |
156 | -48.835 | -72.3481481481 | 67.5 | 70.09 | 17.05 | 1050614 | 30.9108829 | CS |
260 | -45.835 | -71.0620155039 | 64.5 | 93.66 | 17.05 | 1055993 | 40.23520608 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales